Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ALK |
Variant | L1198X |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | ALK L1198X indicates any Alk missense mutation that results in replacement of the leucine (L) at amino acid 1198 by a different amino acid. |
Associated Drug Resistance | |
Category Variants Paths |
ALK mutant ALK L1198X |
Transcript | NM_004304.5 |
gDNA | chr2:g.29220757_29220759 |
cDNA | c.3592_3594 |
Protein | p.L1198 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004304.5 | chr2:g.29220757_29220759 | c.3592_3594 | p.L1198 | RefSeq | GRCh38/hg38 |
NM_004304.4 | chr2:g.29220757_29220759 | c.3592_3594 | p.L1198 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01625234 | Phase Ib/II | Ensartinib | Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer | Completed | USA | 0 |